Norstella is a company based in the United States specializing in business services, particularly within the management consulting and corporate services sectors. Established in 1994, Norstella employs between 1,001 and 5,000 individuals and reported a revenue of approximately $234.9 million. The company focuses on providing insights and guidance throughout the drug development life cycle, addressing the complexities faced by pharmaceutical companies. Their published document, a drug development guide, outlines the stages of drug development, including discovery, preclinical research, clinical trials, regulatory reviews, and post-market safety monitoring. The guide emphasizes the importance of understanding the competitive landscape, risk modeling, and developing effective market access strategies. Norstella aims to assist clients in navigating the highly regulated pharmaceutical environment, ensuring optimal access to products for patients, and adapting to changes in the competitive landscape post-launch. The company's expertise is particularly relevant for organizations looking to streamline their drug development processes and enhance commercialization efforts.